Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-059637

Chief Financial Officer acquired 68,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fenton Mary Kay · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-18 Grant or award : show line 1 in the form +68,750 130,778 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-18 Grant or award : show line 2 in the form Stock Option (Right to Buy) +137,500 137,500 D
Loading xslF345X05/ownership.xml…